Phio Pharmaceuticals Corp. (29)
Browse by Contract Category
Contracts
-
Form of Restricted Stock Unit Award under the Companys 2020 Long Term Incentive Plan
(Filed With SEC on March 25, 2021)
-
Form of Securities Purchase Agreement, dated February 12, 2021, by and between the Company and the Purchasers signatory therein
(Filed With SEC on February 17, 2021)
-
Description of Securities Registered Pursuant to Section 12(b) of the Securities Exchange Act of 1934
(Filed With SEC on March 26, 2020)
-
Placement Agency Agreement, by and between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC dated as of November 18, 2019
(Filed With SEC on November 20, 2019)
-
First Amendment to Lease Dated January 22, 2019
(Filed With SEC on January 28, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on February 17, 2021)
-
Form of Registration Rights Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein
(Filed With SEC on January 25, 2021)
-
Form of Securities Purchase Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein
(Filed With SEC on January 25, 2021)
-
Form of Pre-Funded Common Stock Warrant
(Filed With SEC on January 25, 2021)
-
Form of Common Stock Warrant
(Filed With SEC on January 25, 2021)
-
Securities Purchase Agreement, dated March 31, 2020, by and between the Company and the Purchasers signatory therein
(Filed With SEC on April 2, 2020)
-
Form of Common Stock Warrant
(Filed With SEC on April 2, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on February 13, 2020)
-
Form of Underwriter Common Stock Purchase Warrant
(Filed With SEC on February 13, 2020)
-
Form of Pre-Funded Common Stock Purchase Warrant
(Filed With SEC on February 13, 2020)
-
Underwriting Agreement, dated as of February 11, 2020, between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein
(Filed With SEC on February 13, 2020)
-
Securities Purchase Agreement, dated February 4, 2020, by and between the Company and the Purchasers signatory therein
(Filed With SEC on February 6, 2020)
-
Form of Common Stock Warrant
(Filed With SEC on February 6, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on January 31, 2020)
-
Form of Warrant
(Filed With SEC on January 31, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on January 31, 2020)
-
Form of Underwriter Warrant
(Filed With SEC on January 31, 2020)
-
Form of Placement Agent Warrants of Phio Pharmaceuticals Corp
(Filed With SEC on November 20, 2019)
-
Phio Pharmaceuticals Corp. 2012 Long Term Incentive Plan
(Filed With SEC on November 12, 2019)
-
First Amendment to Purchase Agreement by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on August 30, 2019)
-
Registration Rights Agreement, dated as of August 7, 2019, by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on August 9, 2019)
-
Purchase Agreement, dated as of August 7, 2019 by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on August 9, 2019)
-
Employment Agreement, dated April 22, 2019, between Phio Pharmaceuticals Corp. and John A. Barrett, Ph.D
(Filed With SEC on May 14, 2019)
-
Amendment No. 2 to Cauwenbergh Non-Plan Stock Compensation Election Agreement
(Filed With SEC on February 15, 2019)